These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12769704)

  • 1. Progress in simulation modelling for pharmacokinetics.
    Leahy DE
    Curr Top Med Chem; 2003; 3(11):1257-68. PubMed ID: 12769704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting ADME properties in silico: methods and models.
    Butina D; Segall MD; Frankcombe K
    Drug Discov Today; 2002 Jun; 7(11):S83-8. PubMed ID: 12047885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico ADME-Tox modeling: progress and prospects.
    Alqahtani S
    Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1147-1158. PubMed ID: 28988506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of permeability in drug ADME/PK, interactions and toxicity--presentation of a permeability-based classification system (PCS) for prediction of ADME/PK in humans.
    Fagerholm U
    Pharm Res; 2008 Mar; 25(3):625-38. PubMed ID: 17710514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PK/DB: database for pharmacokinetic properties and predictive in silico ADME models.
    Moda TL; Torres LG; Carrara AE; Andricopulo AD
    Bioinformatics; 2008 Oct; 24(19):2270-1. PubMed ID: 18684738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery.
    Lin J; Sahakian DC; de Morais SM; Xu JJ; Polzer RJ; Winter SM
    Curr Top Med Chem; 2003; 3(10):1125-54. PubMed ID: 12769713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism-based prediction of particle size-dependent dissolution and absorption: cilostazol pharmacokinetics in dogs.
    Willmann S; Thelen K; Becker C; Dressman JB; Lippert J
    Eur J Pharm Biopharm; 2010 Sep; 76(1):83-94. PubMed ID: 20554023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative derivation for the gastrointestinal absorption residence time.
    Chiou WL; Chen TM; Choo YS; Abdel-Hameed MH
    J Pharm Sci; 1992 May; 81(5):486-7. PubMed ID: 1403687
    [No Abstract]   [Full Text] [Related]  

  • 10. Prediction of the plasma concentration profiles of orally administered drugs in rats on the basis of gastrointestinal transit kinetics and absorbability.
    Sawamoto T; Haruta S; Kurosaki Y; Higaki K; Kimura T
    J Pharm Pharmacol; 1997 Apr; 49(4):450-7. PubMed ID: 9232547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A heterogeneous tube model of intestinal drug absorption based on probabilistic concepts.
    Kalampokis A; Argyrakis P; Macheras P
    Pharm Res; 1999 Nov; 16(11):1764-9. PubMed ID: 10571284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling of drug disposition kinetics in in vitro intestinal absorption cell models.
    Heikkinen AT; Korjamo T; Mönkkönen J
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):180-8. PubMed ID: 20030630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADMET in silico modelling: towards prediction paradise?
    van de Waterbeemd H; Gifford E
    Nat Rev Drug Discov; 2003 Mar; 2(3):192-204. PubMed ID: 12612645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in computationally modeling human oral bioavailability.
    Wang J; Hou T
    Adv Drug Deliv Rev; 2015 Jun; 86():11-6. PubMed ID: 25582307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simulation of differential drug pharmacokinetics under heat and exercise stress using a physiologically based pharmacokinetic modeling approach.
    Sidhu P; Peng HT; Cheung B; Edginton A
    Can J Physiol Pharmacol; 2011 May; 89(5):365-82. PubMed ID: 21627485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part II: extension to describe performance of solid dosage forms.
    Thelen K; Coboeken K; Willmann S; Dressman JB; Lippert J
    J Pharm Sci; 2012 Mar; 101(3):1267-80. PubMed ID: 22125236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput and in silico techniques in drug metabolism and pharmacokinetics.
    van de Waterbeemd H
    Curr Opin Drug Discov Devel; 2002 Jan; 5(1):33-43. PubMed ID: 11865671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologically Based Oral Absorption Modelling to Study Gut-Level Drug Interactions.
    Chung J; Kesisoglou F
    J Pharm Sci; 2018 Jan; 107(1):18-23. PubMed ID: 28847476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition.
    Poulin P; Theil FP
    J Pharm Sci; 2002 May; 91(5):1358-70. PubMed ID: 11977112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body physiologically based pharmacokinetic population modelling of oral drug administration: inter-individual variability of cimetidine absorption.
    Willmann S; Edginton AN; Kleine-Besten M; Jantratid E; Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 Jul; 61(7):891-9. PubMed ID: 19589231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.